However, comparable numbers of osteoclasts were observed at the healthy BM/bone interface for both STING-NP–treated and vehicle-treated mice at day 7 (Supplementary Fig. S5B), which suggests that the bone-protective effects of STING-NPs result from the initial reduction in tumor burden. Here, STING1 is linked to neoplasm.